BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17766216)

  • 1. Biloma following transcatheter arterial chemoembolization with microspheres: a case report.
    Huang CK; Chen SC; Shih PM; Chuang WL
    Kaohsiung J Med Sci; 2007 Sep; 23(9):470-4. PubMed ID: 17766216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrahepatic biloma formation (bile duct necrosis) after transcatheter arterial chemoembolization.
    Sakamoto I; Iwanaga S; Nagaoki K; Matsuoka Y; Ashizawa K; Uetani M; Fukuda T; Okimoto T; Okudaira S; Omagari K; Hayashi K; Matsunaga N
    AJR Am J Roentgenol; 2003 Jul; 181(1):79-87. PubMed ID: 12818833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of clinical prognosis and the correlation between bile duct injury after transcatheter arterial chemoembolization and the level of hepatic arterial embolization in patients with hepatocellular carcinoma].
    Xu HY; Yu XP; Feng R; Hu HJ; Xiao WW
    Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):355-360. PubMed ID: 28535652
    [No Abstract]   [Full Text] [Related]  

  • 4. [A case of resection of biloma with hepatocellular carcinoma after embolization].
    Park WK; Chang JC; Lee HZ; Kim HJ; Choi JH; Gu MJ
    Taehan Kan Hakhoe Chi; 2002 Sep; 8(3):331-5. PubMed ID: 12499793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Investigation of bile duct injury after transcatheter arterial chemoembolization].
    Wang MQ; Shao RH; Ye HY; Wang ZQ; Wang ZP; Liu FY
    Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):609-12. PubMed ID: 16438871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Main bile duct stricture occurring after transcatheter arterial chemoembolization for hepatocellular carcinoma.
    Miyayama S; Yamashiro M; Okuda M; Yoshie Y; Nakashima Y; Ikeno H; Orito N; Notsumata K; Watanabe H; Toya D; Tanaka N; Matsui O
    Cardiovasc Intervent Radiol; 2010 Dec; 33(6):1168-79. PubMed ID: 20058008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcatheter arterial chemoembolization with epirubicin-loaded superabsorbent polymer microspheres for 135 hepatocellular carcinoma patients: single-center experience.
    Seki A; Hori S; Kobayashi K; Narumiya S
    Cardiovasc Intervent Radiol; 2011 Jun; 34(3):557-65. PubMed ID: 20821211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pilot study of transcatheter arterial chemoembolization with degradable starch microspheres in patients with hepatocellular carcinoma.
    Furuse J; Ishii H; Satake M; Onaya H; Nose H; Mikami S; Sakai H; Mera K; Maru Y; Yoshino M
    Am J Clin Oncol; 2003 Apr; 26(2):159-64. PubMed ID: 12714888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postmortem survey of bile duct necrosis and biloma in hepatocellular carcinoma after transcatheter arterial chemoembolization therapy: relevance to microvascular damages of peribiliary capillary plexus.
    Kobayashi S; Nakanuma Y; Terada T; Matsui O
    Am J Gastroenterol; 1993 Sep; 88(9):1410-5. PubMed ID: 8395764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transcatheter arterial chemo-embolization using degradable starch microspheres (DSM) markedly effective for post-hepatectomy intra-hepatic recurrence in a patient with cholangioma].
    Niinobu T; Shibata T; Fukushima Y; Kitada M; Tukahara Y; Hata S; Ikeda K; Hayashida H; Fuzita J; Takahashi Y; Nakamura T; Suzuki R; Shimano T; Takami M; Ishida T
    Gan To Kagaku Ryoho; 2000 Oct; 27(12):1931-5. PubMed ID: 11086448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile Duct Injury after Transcatheter Arterial Chemoembolization: Risk Factors and Clinical Implications.
    Wang Z; Wang M; Duan F; Song P; Liu F
    Hepatogastroenterology; 2014 Jun; 61(132):947-53. PubMed ID: 26158147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical features and risk factors of biloma formation after transcatheter arterial chemoembolization].
    Zhaolin Z; Xuelian L; Wensou H; Mingyue C; Haofan W; Ming'an L; Hong S; Zhu K
    Zhonghua Yi Xue Za Zhi; 2015 Apr; 95(13):1002-5. PubMed ID: 26506711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transhepatic arterial chemoembolization by epirubicin mixed with microspheres for hepatocellular carcinoma].
    Luo JJ; Yan ZP; Wang JH; Liu QX; Chen Y
    Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):619-22. PubMed ID: 18210885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common Bile Duct Obstructed by Lipiodol After Transcater Arterial Chemoembolization for Hepatocellular Carcinoma: A Case Report.
    Zhang F; Xu J; Zhu Y; Shi Y; Chen S; Jin Z; Jiang Y; Wang H
    Curr Med Imaging; 2023; 19(14):1689-1695. PubMed ID: 36788684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biliary complications of arterial chemoembolization of hepatocellular carcinoma.
    Dhamija E; Paul SB; Gamanagatti SR; Acharya SK
    Diagn Interv Imaging; 2015 Nov; 96(11):1169-75. PubMed ID: 26292615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Balloon-Occluded Transcatheter Arterial Chemoembolization (b-TACE) for Hepatocellular Carcinoma Performed with Polyethylene-Glycol Epirubicin-Loaded Drug-Eluting Embolics: Safety and Preliminary Results.
    Lucatelli P; Ginnani Corradini L; De Rubeis G; Rocco B; Basilico F; Cannavale A; Nardis PG; Corona M; Saba L; Catalano C; Bezzi M
    Cardiovasc Intervent Radiol; 2019 Jun; 42(6):853-862. PubMed ID: 30843093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arteritis following intra-arterial chemotherapy for liver tumors.
    Belli L; Magistretti G; Puricelli GP; Damiani G; Colombo E; Cornalba GP
    Eur Radiol; 1997; 7(3):323-6. PubMed ID: 9087350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features and treatment of hepatic abscesses with biloma formation after transcatheter arterial chemoembolization.
    Zhu M; Li G; Chen Y; Gong G; Guo W
    Arab J Gastroenterol; 2022 Feb; 23(1):32-38. PubMed ID: 35153174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abdominal wall necrosis following transcatheter arterial chemoembolization for hepatocellular carcinoma.
    Liu HJ; Chen TS; Lee RC; Ho DM; Lin JT; Chu LS; Chang FY
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Nov; 63(11):838-43. PubMed ID: 11155762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switching the loaded agent from epirubicin to cisplatin: salvage transcatheter arterial chemoembolization with drug-eluting microspheres for unresectable hepatocellular carcinoma.
    Seki A; Hori S
    Cardiovasc Intervent Radiol; 2012 Jun; 35(3):555-62. PubMed ID: 21562932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.